PUBLICATION

Peroxisomal proliferator-activated receptor α-b deficiency induces the reprogramming of nutrient metabolism in zebrafish

Authors
Li, L.Y., Lv, H.B., Jiang, Z.Y., Qiao, F., Chen, L.Q., Zhang, M.L., Du, Z.Y.
ID
ZDB-PUB-200728-21
Date
2020
Source
The Journal of physiology   598(20): 4537-4553 (Journal)
Registered Authors
Du, Zhen-Yu, Qiao, Fang, Zhang, Mei-Ling
Keywords
PPARα, fatty acid β-oxidation, glucose utilization, lipid homeostasis, metabolic reprogramming, protein deposition, zebrafish
MeSH Terms
  • Animals
  • Fatty Acids/metabolism
  • Lipid Metabolism
  • Liver/metabolism
  • Nutrients
  • PPAR alpha*/genetics
  • PPAR alpha*/metabolism
  • Phosphatidylinositol 3-Kinases/metabolism
  • Zebrafish*
PubMed
32710562 Full text @ J. Physiol.
Abstract
The pparab subtype in zebrafish is much more highly expressed in tissues with high oxidative activity than pparaa. The pparab deficiency in zebrafish reduces FAO both in liver and muscle, illustrating its functional homology as mammalian PPARα. The pparab deficiency promotes metabolic reprogramming by increasing glucose utilization and inhibiting amino acid breakdown. Our study brings new insights into the comprehensive regulatory roles of PPARα in the cellular fuel selection and provides a valuable animal model for PPARα studies from a viewpoint of comparative physiology.
Dysfunction of lipid metabolism is involved in the pathogenesis of several chronic metabolic diseases. Peroxisome proliferator-activated receptor α (PPARα) is essential for normal metabolic homeostasis, and in particular for the regulation of fatty acid β-oxidation (FAO). However, little is known about its regulation roles in systemic nutrient metabolism. To explore the underlying modulation role of PPARα in metabolic homeostasis, we generated a pparab-knockout zebrafish (Danio rerio) model. The pparab mutants demonstrated lower expression of key enzymes involved in FAO, and lower mitochondrial and peroxisomal FAO in tissues, which was associated with lipid accumulation in liver and visceral mass. Conversely, glucose utilization was higher, because they demonstrated lower blood glucose and tissue glycogen concentrations, and activation of the phosphoinositide 3-kinase/AKT pathway. In addition, the pparab-deficient zebrafish demonstrated activation of AKT/mammalian target of rapamycin (mTOR) signalling and higher protein content, implying greater protein synthesis and/or lower amino acid breakdown. These data clearly revealed that pparab deletion reduces FAO, but increases glucose utilization and protein deposition, to maintain energy homeostasis. This study provides new insights into the comprehensive regulatory role of PPARα in systemic energy metabolism in fish, and this pparab-deficient zebrafish also constitutes a valuable model for studying the functions of PPARα in mammals from comparative physiology aspects. This article is protected by copyright. All rights reserved.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping